BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 2219961)

  • 1. In vitro metabolism of the antianxiety drug buspirone as a predictor of its metabolism in vivo.
    Jajoo HK; Blair IA; Klunk LJ; Mayol RF
    Xenobiotica; 1990 Aug; 20(8):779-86. PubMed ID: 2219961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of the antianxiety drug buspirone in the rat.
    Jajoo HK; Mayol RF; LaBudde JA; Blair IA
    Drug Metab Dispos; 1989; 17(6):625-33. PubMed ID: 2575498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of the antianxiety drug buspirone in human subjects.
    Jajoo HK; Mayol RF; LaBudde JA; Blair IA
    Drug Metab Dispos; 1989; 17(6):634-40. PubMed ID: 2575499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
    Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D
    Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biotransformation of lovastatin. II. In vitro metabolism by rat and mouse liver microsomes and involvement of cytochrome P-450 in dehydrogenation of lovastatin.
    Vyas KP; Kari PH; Prakash SR; Duggan DE
    Drug Metab Dispos; 1990; 18(2):218-22. PubMed ID: 1971576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the aromatic hydroxylation of amphetamine in rat liver microsomes and perfused liver preparations: effects of long-term administration.
    Jonsson J
    Acta Pharmacol Toxicol (Copenh); 1977 Apr; 40(4):517-28. PubMed ID: 16430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450 inactivation during reductive metabolism of 1,1-dichloro-2,2,2-trifluoroethane (HCFC-123) by phenobarbital- and pyridine-induced rat liver microsomes.
    Ferrara R; Tolando R; King LJ; Manno M
    Toxicol Appl Pharmacol; 1997 Apr; 143(2):420-8. PubMed ID: 9144458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-electron reduction of mitomycin c by rat liver: role of cytochrome P-450 and NADPH-cytochrome P-450 reductase.
    Vromans RM; van de Straat R; Groeneveld M; Vermeulen NP
    Xenobiotica; 1990 Sep; 20(9):967-78. PubMed ID: 2122607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative metabolism of flunarizine in rats, dogs and man: an in vitro study with subcellular liver fractions and isolated hepatocytes.
    Lavrijsen K; van Houdt J; van Dyck D; Hendrickx J; Bockx M; Hurkmans R; Meuldermans W; Le Jeune L; Lauwers W; Heykants J
    Xenobiotica; 1992 Jul; 22(7):815-36. PubMed ID: 1455902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of hydroxy derivatives, aldehydes, and nitrite from N-nitrosomethyl-n-amylamine by rat liver microsomes and by purified cytochrome P-450 IIB1.
    Ji C; Mirvish SS; Nickols J; Ishizaki H; Lee MJ; Yang CS
    Cancer Res; 1989 Oct; 49(19):5299-304. PubMed ID: 2766298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of metoprolol in the rat in vitro and in vivo.
    Arfwidsson A; Borg KO; Hoffmann KJ; Skånberg I
    Xenobiotica; 1976 Nov; 6(11):691-711. PubMed ID: 997586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of antiparkinson agent dopazinol by rat liver microsomes.
    Vyas KP; Kari PH; Ramjit HG; Pitzenberger SM; Hichens M
    Drug Metab Dispos; 1990; 18(6):1025-30. PubMed ID: 1981508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro biotransformation of finasteride in rat hepatic microsomes. Isolation and characterization of metabolites.
    Ishii Y; Mukoyama H; Ohtawa M
    Drug Metab Dispos; 1994; 22(1):79-84. PubMed ID: 8149894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of 7,8-dihydrobenzo(a)pyrene by rat liver microsomal enzymes and mutagenicity of metabolites.
    Chiu PL; Yang SK
    Cancer Res; 1986 Oct; 46(10):5084-94. PubMed ID: 3756866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of two metyrapone N-oxides by rat liver microsomes.
    De Graeve J; Gielen JE; Kahl GF; Tüttenberg KH; Kahl R; Maume B
    Drug Metab Dispos; 1979; 7(3):166-70. PubMed ID: 38088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study on the Prethcamide hydroxylation system in rat hepatic microsomes.
    Szumiło T; Bryła P; Byra A
    Acta Biochim Pol; 1984; 31(4):409-19. PubMed ID: 6543484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The metabolism of 1-phenyl-2-(N-methyl-N-furfurylamino)propane (furfenorex) in the rat in vivo and in vitro.
    Inoue T; Yasuda T; Suzuki S; Kishi T; Niwaguchi T
    Xenobiotica; 1986 Feb; 16(2):109-21. PubMed ID: 3962333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolism of drugs in isolated rat hepatocytes. A comparison with in vivo drug metabolism and drug metabolism in subcellular liver fractions.
    Billings RE; McMahon RE; Ashmore J; Wagle SR
    Drug Metab Dispos; 1977; 5(6):518-26. PubMed ID: 21776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2,2',5,5'-Tetrachlorobiphenyl: isolation and identification of metabolites generated by rat liver microsomes.
    Preston BD; Allen JR
    Drug Metab Dispos; 1980; 8(4):197-204. PubMed ID: 6105050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of diamantane by rat liver microsomal cytochromes P-450.
    Hodek P; Janscák P; Anzenbacher P; Burkhard J; Janků J; Vodicka L
    Xenobiotica; 1988 Oct; 18(10):1109-18. PubMed ID: 3242307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.